SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Moonwalk Biosciences, a pioneering epigenetic engineering and medicine company, announced it will present data highlighting its EpiRead and ...

Andrew Feinberg, Bloomberg Distinguished Professor of Epigenetics at Johns Hopkins University Schools of Medicine, Engineering and Public Health, has been awarded the 2026 AACR-G.H.A. Clowes Award for ...

It will be interesting to see where companies developing therapeutics based on epigenome editing technology choose to focus their development efforts over the next few years. For Moonwalk Biosciences ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...

Salk Institute researchers find new mode of epigenetic targeting, showing for the first time that genetic sequences can direct new DNA methylation patterns in plants LA JOLLA (November 21, 2025)—All ...

RICHMOND, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 20 ...

Episode 3 (January 5, 2024): Interview with co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look ...

The EpiRead and EpiWrite platform will be presented for the first time highlighting high-resolution single-cell mapping of the methylome in conjunction with targeted methylation modifications.

The MarketWatch News Department was not involved in the creation of this content. -- The EpiRead and EpiWrite platform will be presented for the first time highlighting high-resolution single-cell ...